HOXA9-PBX1 axis orchestrates divergent Th2 cytokine expression

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Homeobox A9 (HOXA9) is known for its roles in hematopoiesis and leukemogenesis.
• The function of HOXA9 in CD4+ T helper 2 (Th2) cell development remains largely uncharacterized.
• Th2 cells are implicated in the pathogenesis of various autoimmune disorders.

Purpose of the Study:

• To investigate the role of HOXA9 in Th2 cell development and function.
• To elucidate the molecular mechanisms by which HOXA9 regulates Th2-specific cytokine production.
• To identify potential cofactors interacting with HOXA9 in Th2 cells.

Main Methods:

• Overexpression of HOXA9 in Th2 cells.
• Analysis of cytokine secretion (IL-4, IL-13, IL-10).
• Promoter activity assays and investigation of protein-protein interactions (HOXA9, PU.1, PBX1, GATA3).
• Chromatin immunoprecipitation (ChIP) to assess DNA binding.

Main Results:

• HOXA9 overexpression increased IL-10 secretion while suppressing IL-4 and IL-13 in Th2 cells.
• HOXA9 physically interacted with PU.1 and PBX1, but not GATA3, and bound to PU.1 loci.
• The HOXA9-PBX1 axis significantly influenced IL-10 production, particularly at the Il10 gene promoter.

Conclusions:

• HOXA9 plays a critical role in regulating Th2 cell differentiation and cytokine profiles.
• PBX1 acts as a coregulator for HOXA9 in Th2 cell function, modulating cytokine output.
• The HOXA9-PBX1 pathway is a key regulator of IL-10 production in Th2 cells, offering insights into autoimmune disease mechanisms.